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Background: Since cardiovascular diseases are associated with
high mortality and generally, there is a need for a reliable tool for
early diagnosis. Ankle brachial index (ABI) is a non-invasive
marker of coronary artery disease (CAD) and is an inexpensive,
reliable, and reproducible method. The current study aims to
determine the relation between ankleebrachial index (ABI) and
angiographic findings and major cardiovascular risk factors in
patients with suspected coronary artery diseases (CAD).
Methods: In this prospective observational study, patients with
suspected CAD were studied. Characteristics of studied subjects
including atherosclerotic risk factors such as diabetes mellitus,
hypertension, hyperlipidemia and smoking were obtained. ABI
was measured in all studied patients. ABI  0.9 (ABI+) was
considered as peripheral vessel disease and ABI >0.9 (ABI-) was
considered as normal.
Then, all studied patients underwent coronary artery angiog-
raphy. The results of the angiographic findings were compared in
ABI+ and ABI- groups.
Results: In this study, 100 patients were investigated. ABI  0.9
was seen in 20 patients (20%).The prevalence of ABI+ among men
and women was 26% and 7%, respectively (P ¼ 0.01).
The prevalence of atherosclerotic risk factors was significantly
higher in ABI+ patients than in ABI (-) ones (P < 0.05).
ABI+ patients had more significant stenosis than ABI(- )ones.
The mean of occlusion was significantly higher in ABI+ patients
with left main artery (LMA), right coronary artery (RCA), left
anterior descending artery (LAD), and left circumflex artery (LCX)
involvements (P < 0.05).
Conclusion: The findings of this study indicated that ABI could be
a useful method in assessing both the atherosclerotic risk factors
and the degree of coronary involvements in suspected patients.
Thrombolysis success rate beyond 90 minutes
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Background: The aim of the study was to assess the thrombolysis
success rate beyond 90 minutes. Conventionally we assess the
success rate at 90 minutes after thrombolysis. In our study we
assessed the success rate at 120 minutes and at 180 minutes.
Methods and Results: 200 STEMI patients were enrolled. About
65% are anterior wall MI, remaining are Inferior wall MI. Median
delay was 4.5 hours on average. All are thrombolysed with
streptokinase after ruling out contraindication for thrombolysis.
Success rate at 90 minutes were 42%, at 120 minutes were addi-
tional 18% and at 120minutes were additional 11%. Echowas done
to all the patients before thrombolysis, 24 hours, before discharge
and at 1month. Ejection fraction in all the groupswas comparable
with insignificant P value. But EF after 120 minutes was compar-
atively low. Coronary angiogram was done to all the patients
within 24 hours after thrombolysis. The TIMI flow also was com-
parable in all the three groups. In analysis we found that 90 mi-
nutes group were younger age group and had high percentage of
single vessel disease. The other two groups were little older and
had two vessel and triple vessel disease compared to 90 minutes
group.
Conclusions: Success rate of thrombolysis with streptokinase at
90minutes was 42% only but at 120minutes there were additional
18% and at 120 minutes were additional 11% patients with suc-
cessful thrombolysis.
Clinical and angiographic profile of ACS patients
and their short-term outcomes
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Background: Spectrum of ACS patients is variable across
geographical areas and also in various institutes in same area.
Methods: ACS patients were evaluated for presenting clinical fea-
tures, risk factor profile, in-hospital course and 6-month outcome.
Results: 516 ACS patients were enrolled, 30.8% STEMI and 69.2%
NSTMI/UA. 65.1% were male and 34.9% female. Median age was
56years. STEMI 53yrs and NSTMI/UA 59 yrs.
52.5% patients were smoker, 63.5% in STEMI & 47.6% in NSTMI/
UA group. 36.6% patients were diabetic & 35.6% were hyperten-
sive. 41.3% were Dyslipidaemic 33.3% in STEMI and 44.8% in
NSTMI/UA group. Peripheral vascular disease was found in 7%
patients. 6% patients had family history of CAD. 15.3% and 10.4%
were post PTCA & post CABG respectively.
1.4% patients presented with cardiac arrest (STEMI 3.1% &
NSTMI/UA 0.5%). 3.6% patients developed cardiogenic shock
[STEMI-7.5% & NSTMI/UA-1.9%], P-value <0.001. 4.4% patients
developed atrial fibrillation (STEMI-5.6% & NSTMI/UA-13.6%). AV
block developed in 5.3% patients (STEMI-9.4% & NSTMI/UA-3.3%).
4.3% patients had VT.Major hemorrhage occurred in 1.7% patients
(STEMI- 4.4% & NSTMI-0.5%). CVA occurred in 1.7% patients
[STEMI 1.8%, NSTMI/UA 0.5%]. Median hospital stay was 5 days.
81.2% patients underwent coronary angiography.38.9%, 26.8%
&24.4% patients had SVD, DVD& TVD respectively, 4.8% had LMCA
disease. In STEMI groupmorepatients had SVD45.7%as compare to
NSTMI/UAgroup29%,p-valuep<0.001. InSTEMI group19.3%& 3.8%
and in NSTMI/UA group 26.8% & 24.4% patients had DVD and TVD
respectively. In-hospital death ratewas 4.84%. 8.1% in STEMI& 3.3%
in NSTMI/UA. Cause of death was cardiogenic shock 48%, LVF 28%,
mechanical complication 8%, Arrhythmia 4%, and bleeding 4%. 6-
month mortality was 6.3%, STEMI 8.9% and NSTMI/UA 5.1%.
Conclusions: ACS occurs at relatively young age in Indians.
Smoking and Dyslipidaemia were most prevalent risk factors. In
STEMI patients SVD is more frequent.
To validate the GRACE risk score in Indian ACS
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Background: Due to Geographic and racial variability of acute
coronary syndrome patients, risk scores need validation for
particular population.
Methods: In 516 ACS patients GRACE risk score for in-hospital and
6-monthmortality was calculated according to the Eagle’s original
model. Index of discrimination was used to assess the perfor-
mance of the GRACE score. Calibration tool was used to assess
how closely the predicted event rate approximates the observed
event rate.
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Results: Median GRACE in-Hospital and 6 month mortality score
was 139 and 131 respectively. The observed mortality showed
gradient according to GRACE risk score, being lowest in Low risk,
increased in Intermediate Risk and highest in High risk group.
In hospital and 6 month, Observed & anticipated mortality, HLp
value for calibration and C statistics for discrimination is shown in
Table.
The Hosmer-Lemeshow P-value between 0.31 to 0.51 shows that
the calibration power of GRACE score for observed against pre-
dicted, in-hospital as well as 6-month mortality is acceptable for
all subsets of ACS population.
C statistics of close to 0.8 shows good discrimination power of
GRACE risk score for all subgroups of ACS patients.
Conclusion: GRACE Score is accurate, with good calibration and
discrimination power to predict mortality in Indian ACS patients
and can be used for risk stratification and deciding the manage-
ment strategy.
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Challenges in dietary intervention
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Background and Rationale: Dietary intervention in atherosclerosis
is difficult for reasons such as longer duration for the impact to be
evident, maintaining the compliance up to the end and to balance
the other contributing factors. This is the first study in literature on
the effect of cooking oil media on cardiovascular risk factors and
lipid profiles and cardiac events. This study evaluated the effect of
the most commonly used cooking media in the state of Kerala to
answer the question what oil to be used after cardiac events.
Design andMethods: Two hundred patients with proven coronary
artery disease on standard medical care were (100 each) assigned
to coconut oil or sunflower oil as a cooking oil media for 2 years.
Total 1200 clinical visits were carried out and collected data on
anthropometry, lipids, lipoproteins, antioxidants flow mediated
vasodilation and cardiac events.
Study compliance to a particular oil arm was assured by using 3
tools: 24 hour recall, 7 Day recall and diet dairy.
Results: Recruitments was completed in 3 yrs. The reason for the
delay were patient decision to change over to a particular oil.
Family acceptance of the need for special cooking pattern.
Consent to undergo study related visits and blood test.
99% patients in each arm adhered to the oil assigned. All pa-
tients completed the final visit. Except for the particular oil all
other factors including the calories derived from major foodstuff
were maintained equal in both groups.
There is no statistically significant difference in the anthropo-
metric, biochemical, vascular function and in cardiovascular
events in patients with CAD while using either coconut oil or
sunflower oil as cooking media over a period of 2 years.
Conclusion: Even though difficult for many reasons, long term
dietary interventions in atherosclerosis is possible with meticu-
lous planning and by using study compliance techniques.
Effect of Ranolazine on angina frequency in
patients with Type 2 DM and Chronic stable
angina
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Background: Patients with diabetes have extensive CAD. Ranola-
zine is effective in treating angina andmay also improve glycemic
control. We conducted a randomized trial to test the antianginal
benefit of ranolazine in patients with diabetes and stable angina.
Objectives: Evaluate efficacy of ranolazineversusplacebo onangina
frequency and use of sublingual isosorbide dinitrate tablets in pa-
tients with type 2 Diabetes and stable angina who remain symp-
tomatic despite treatment with 1 or 2 anti-anginal medications.
Methods: This was a trial of ranolazine versus placebo in patients
with diabetes and stable angina treated with 1 to 2 antianginals.
185 patients were randomized to ranolazine and placebo group.
Anginal episodes and isosorbide dinitrate use were recorded with
daily entry into a diary. Primary outcome was the average weekly
number of anginal episodes over the last 6 weeks of the study.
Results: A total of 185 patients were randomized. Mean age was
62.35±1.18years, 58.92%weremen,meandiabetesdurationwas7.2
years, and mean baseline HbA1c was 6.75%. Weekly angina fre-
quency was significantly lower with ranolazine versus placebo (4.8
[95%confidence interval (CI): 4.6 to 5.1] episodesvs. 5.3 [95%CI: 5.0 to
5.5] episodes,p¼0.004), aswas theweeklysublingualnitrateuse (2.7
[95% CI: 2.6 to 2.9] doses vs. 3.1 [95% CI: 2.9 to 3.3] doses, p ¼ 0.002).
Conclusions: Among patients with diabetes and chronic angina,
ranolazine reduced angina and sublingual nitrate use and was
well tolerated.
Psychosocial risk factors and recent ACS e A case
control study
Gaurav Gupta, C.M. Varma, R. Thakur, R.P.S. Bhardwaj,
M. Ahmad, R.K. Bansal, U. Pandey, S.K. Sinha, P. Kumar
Table- Discrimination & Calibration power of GRACE score
Patient no. Observed
mortality %
Anticipated
mortality %
Hosmer-Lemeshow
P-value
C statistics AUC-ROC
(95% CI)
In-hospital
Total 516 4.84 4.4 0.51 0.80(0.78-0.81)
STEMI 159 8.1 7.7 0.43 0.81(0.78-0.81)
NSTEMI/UA 357 3.3 3.1 0.39 0.78(0.76-0.80)
6-month
Total 445 6.3 5.9 0.41 0.79(0.77-0.82)
STEMI 134 8.9 8.4 0.32 0.81(0.77-0.83)
NSTEMI/UA 311 5.1 4.8 0.31 0.77(0.74-0.82)
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